Panax notoginseng saponins alleviate osteoporosis and joint destruction in rabbits with antigen-induced arthritis

Exp Ther Med. 2021 Nov;22(5):1302. doi: 10.3892/etm.2021.10737. Epub 2021 Sep 16.

Abstract

Although a number of anti-rheumatic drugs and biologics may be used to alleviate the symptoms of rheumatoid arthritis (RA), these compounds have been associated with bone loss and joint destruction; thus, alternative treatment approaches are required. In the present study, various plant extracts were evaluated for their capacity to inhibit joint destruction, and Panax notoginseng saponins (PNS), obtained from the Traditional Chinese Medicine Panax notoginseng, was identified as such a compound. Therefore, a rabbit antigen-induced arthritis (AIA) model was generated by immunization with ovalbumin in Freund's complete adjuvant, followed by treatment with PNS for 3 months. The morphology of the quadriceps femoris muscle, cartilage chondrocytes and skeletal elements was histologically observed by transmission electron microscopy (TEM), as well as micro-computed tomography. The results revealed that PNS significantly reduced the histopathological alterations associated with arthritic muscular atrophy and inflammation. In addition, TEM demonstrated that PNS protected chondrocytes from RA-associated damage. Furthermore, the bone density and microarchitecture in rabbits treated with PNS were markedly improved compared with those of the model group. Collectively, these data indicated that treatment with PNS may relieve osteoporosis and prevent joint and bone destruction in AIA.

Keywords: Panax notoginseng saponins; antigen-induced arthritis; joint destruction; osteoporosis; rheumatoid arthritis.

Grants and funding

Funding: The present study was supported by the Shanghai Science and Technology Commission (grant no. 19401935400), the construction project of Li Fei Yue's National Famous TCM (grant no. MLZJGZS-2017001), the Construction Project of Li Fei Yue's Shanghai Famous TCM Research Studio (grant no. SHGZS-2017010) the National Natural Science Foundation of China (grant no. 81302987) and the National Training Program for Innovative Talents of Traditional Chinese Medicine.